We bring you the latest news from the healthcare about the health care in the United Kingdom.

vrijdag 23 maart 2018

Nature Reviews Gastroenterology & Hepatology - Table of Contents alert Volume 15 Issue 4

If you are unable to see the message below, click here to view.
Nature Reviews Gastroenterology & Hepatology
 

Advertisement
Do you have a career question? 

The Naturejobs podcast features one-on-one Q&As, panel discussions and other exclusive content to help scientists with their careers. Hosted on the Naturejobs blog, the podcast is also available on iTunes and Soundcloud. 

Listen today! 
 
TABLE OF CONTENTS
 
April 2018 Volume 15 Number 4
 
Nature Reviews Gastroenterology & Hepatology cover
2016 2-year Impact Factor 13.678 Journal Metrics 2-year Median 8
In this issue
Research Highlights
News and Views
Correspondence
Reviews
 
Also this month
 Featured article:
Role of priority effects in the early-life assembly of the gut microbiota
Daniel Sprockett, Tadashi Fukami & David A. Relman

 
 

 
Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
   
Advertisement
BAPTIST HEALTH MEDICAL GROUP IS SEEKING HIGHLY QUALIFIED AND MOTIVATED BC/BE 
GASTROENTEROLOGISTS
to join well-established, growing practices in Kentucky. Opportunities are available in Corbin, Madisonville, Paducah and Richmond. Practice may include ERCP or EUS, as desired. Endoscopy suites offer high definition equipment with in-room capabilities at most locations.

For more information, contact a recruiter at FindYourFuture@BHSI.com.
 
Advertisement
Nature Collection: Gut-brain axis 

This Nature Collection brings together Research, Reviews and News from across the Nature Research journals and presents a selection of articles covering key aspects of the gut-brain axis including the gut microbiota and immune, neuroendocrine and neural factors. 

Access this collection >> 

Produced with support from: 
Abbott 
 
RESEARCH HIGHLIGHTS
 
Top

Gastrointestinal cancer: Organoids predict clinical responses
Published online: 14 March 2018
p189 | doi:10.1038/nrgastro.2018.25

PDF


IBD: Functional characterization of an IBD risk gene
Published online: 21 February 2018
p190 | doi:10.1038/nrgastro.2018.17

PDF


Therapy: FMT: the rules of engraftment
Published online: 28 February 2018
p190 | doi:10.1038/nrgastro.2018.19

PDF


Colorectal cancer: Evading the immune response in metastasis
Published online: 28 February 2018
p191 | doi:10.1038/nrgastro.2018.18

PDF


 


IN BRIEF

Liver cancer: Lenvatinib non-inferior to sorafenib for hepatocellular carcinoma | Viral hepatitis: A new model for HBV infection of primary human hepatocytes | Surgery: Describing the global burden of infection after gastrointestinal surgery
PDF

Nature Reviews Gastroenterology & Hepatology
JOBS of the week
Gastroenterologist
St. Vincent Medical Group
Gastroenterology
Billings Clinic
Gastroenterologist Opportunities
The Permanente Medical Group, Inc
Assistant / Associate Professor Medicine Gastroenterology
Stony Brook University
BE / BC Gastroenterologist
Central Maine Medical Center
More Science jobs from
Nature Reviews Gastroenterology & Hepatology
EVENT
The 5th Singapore Hepatology Conference and the best of EASL (SHC-EASL)
08.06.18
Singapore, Singapore
More science events from
 
NEWS AND VIEWS
 
Top
Gut microbiota: Beyond metagenomics, metatranscriptomics illuminates microbiome functionality in IBD
Aonghus Lavelle & Harry Sokol

Published online: 21 February 2018
p193 | doi:10.1038/nrgastro.2018.15

Although metagenomic sequencing has provided unprecedented characterization of the gut microbiome, it gives only indirect evidence of the genes and pathways that might be active. Now, investigators have combined longitudinal sampling with metatranscriptomics and metagenomics in IBD to provide a high-resolution picture of the microbiome's functional dynamics.
Full Text | PDF

 
Hepatitis: No cure for hepatitis B and D without targeting integrated viral DNA?
Markus Cornberg & Michael P. Manns

Published online: 31 January 2018
p195 | doi:10.1038/nrgastro.2017.185

RNA interference (RNAi) is a novel concept to target transcripts derived from HBV covalently closed circular DNA. The study by Wooddell et al. investigates the RNAi-based therapy ARC-520 in patients and chimpanzees with chronic HBV infection and uncovers HBV DNA integration as a crucial source of hepatitis B surface antigen, which has not been considered in current strategies to accomplish HBV cure.
Full Text | PDF

 
 
CORRESPONDENCE
 
Top
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis: a role for bifidobacteria and lactobacilli?
Borja Sanchez

Published online: 07 March 2018
p205 | doi:10.1038/nrgastro.2018.23

Full Text | PDF
 
 
REPLY
 
Top
Probiotics, bile acids and gastrointestinal carcinogenesis
Wei Jia & Guoxiang Xie

Published online: 07 March 2018
p205 | doi:10.1038/nrgastro.2018.24

Full Text | PDF
 
 
 
REVIEWS
 
Top
Role of priority effects in the early-life assembly of the gut microbiota
Daniel Sprockett, Tadashi Fukami & David A. Relman

Published online: 24 January 2018
p197 | doi:10.1038/nrgastro.2017.173

The human gut microbiota undergoes dramatic development early in life. Here, the authors explore how this development is influenced by priority effects, whereby the order and timing of microbial species arrival affect community assembly. In turn, factors affecting order and timing, including delivery mode, diet and parenting behaviours, are also discussed.
Abstract | Full Text | PDF

 
Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system
Masaki Honda & Paul Kubes

Published online: 31 January 2018
p206 | doi:10.1038/nrgastro.2017.183

Neutrophil extracellular traps (NETs) have an important role during infection but they are also related to the exacerbation of inflammation and the development of autoimmunity, cancer metastasis and inappropriate thrombosis. Here, the authors focus on the role of NETs in the liver and gastrointestinal system, outlining their protective and pathological effects and their potential for therapeutic intervention.
Abstract | Full Text | PDF

 
Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management
Mark A. Samaan et al.

Published online: 07 March 2018
p222 | doi:10.1038/nrgastro.2018.14

Immune checkpoint inhibitors are a novel approach to cancer immunotherapy. However, they are associated with substantial risk of immune-related adverse events, including gastrointestinal toxicity. This Review explores the manifestations of gastrointestinal toxicity with immune checkpoint inhibitor use and insights into its management.
Abstract | Full Text | PDF

 
Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends
Peter S. N. van Rossum, Nadia Haj Mohammad, Frank P. Vleggaar & Richard van Hillegersberg

Published online: 13 December 2017
p235 | doi:10.1038/nrgastro.2017.162

Approximately half of patients diagnosed with oesophageal cancer have metastatic or unresectable disease. Here, the authors discuss the multidisciplinary interventions available to manage dysphagia, improve quality of life and prolong survival in these individuals.
Abstract | Full Text | PDF

 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature